<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Boostara Innovations — Medical AI Live Gazette & Research Feed</title>
  <link>https://boostarainnovations.com</link>
  <description>Official News, Clinical Preprints, and Autonomous Diagnostic Telemetry from Boostara Innovations, creator of Boostara Medical AI.</description>
  <language>en-us</language>
  <lastBuildDate>Tue, 29 Sep 2026 14:00:00 GMT</lastBuildDate>
  <atom:link href="https://boostarainnovations.com/feed.xml" rel="self" type="application/rss+xml" />

  <item>
    <title>Boostara Medical AI Achieves Historical 99.8% Concordance in 14-Center Diagnostic Audit</title>
    <link>https://boostarainnovations.com/news.html#clinical-audit-2026</link>
    <description>In the largest independent evaluation of autonomous clinical intelligence, Boostara Foundation Model 9 demonstrated 99.8% diagnostic precision across 125,000 multi-spectral DICOM cases, eliminating nocturnal radiologist fatigue errors.</description>
    <pubDate>Mon, 28 Sep 2026 09:30:00 GMT</pubDate>
    <guid>https://boostarainnovations.com/news.html#clinical-audit-2026</guid>
  </item>

  <item>
    <title>Boostara X-Ray AI Crosses 50,000 Verified Clinician Installs on Google Play Store</title>
    <link>https://play.google.com/store/apps/details?id=com.boostarainnovations.boostarax_xrayai</link>
    <description>Healthcare workers across 140 countries are deploying Boostara X-Ray AI directly from Google Play, enabling instant 140ms pulmonary, cardiac, and trauma evaluations at the bedside.</description>
    <pubDate>Fri, 25 Sep 2026 11:15:00 GMT</pubDate>
    <guid>https://boostarainnovations.com/news.html#play-store-milestone</guid>
  </item>

  <item>
    <title>Limitless Dermatology Vision Core Released: 4,000+ Pathologies Mapped Across All Skin Tones</title>
    <link>https://boostarainnovations.com/capabilities.html#dermatology</link>
    <description>Boostara Innovations announces an ethical and clinical milestone: autonomous recognition of malignant melanomas, carcinomas, and inflammatory rashes across Fitzpatrick phototypes I through VI with zero racial skin-tone bias.</description>
    <pubDate>Wed, 23 Sep 2026 16:45:00 GMT</pubDate>
    <guid>https://boostarainnovations.com/news.html#limitless-dermatology</guid>
  </item>
</channel>
</rss>
